We know we have asked you to do a lot over the last several months. You have faithfully called Congress time and again to tell them to #KillTheBill. We thank you! We know that you may be feeling fatigued. That is EXACTLY what the Republicans want to happen. We CANNOT let up. We CANNOT stop […]
Take Action! Tuesday, July 18, is National HIV Call-In Day! Read More »
“Probiotic supplementation improved the physical and immunological integrity of the intestinal mucosal barrier in HIV-1-positive patients being treated with antiretroviral therapy, according to new research. The researchers sought to evaluate the effects of a high potency multistrain probiotic — marketed in the U.S. as Visbiome (ExeGi Pharma) and Vivomixx in Europe — on intestinal
Probiotic Visbiome improves gut barrier function in patients with HIV Read More »
Gilead presented some data about a new capsid formation inhibitor (GS-CA1), a total new drug class that looks incredibly powerful in vitro (6) [ CROI: Discovery of Novel Potent HIV Capsid Inhibitors with Long-Acting Potential.] These compounds block the capsid formation during maturation and early after entry. They do not have cross resistance with other
New HIV Drugs in the Pipeline- 2017: CROI Review by Dr Pablo Tebas Read More »
Nelson Vergel (PowerUSA.org) moderates a webcast with two leading HIV Cure research activists: Richard Jeffreys and Robert Reinhard. They update us on progress made after a cure was possible for Timothy Brown, the only person cured of HIV in 2007. ABOUT THE SPEAKERS: Richard Jefferys began working in the HIV/AIDS field in 1993 at the
HIV Cure Update 2017: Interview with Leading Research Advocates Read More »
No one can deny that many patients can now suppress their HIV with effective antiretrovirals (ARVs) that cause fewer side effects. However, a vulnerable and often forgotten minority of people are still struggling with multi-drug resistant HIV (MDR-HIV) while they anxiously wait for access to lifesaving ARVs that would finally control their viral replication. Although
Ibalizumab: First Long Acting HIV Treatment Available Now Via Expanded Access Read More »
Background: HIV infected (HIV+) individuals are now reaching an advanced age, through stable treatment with highly active anti-retroviral therapy (HAART). However, HIV and aging are still risk factors for cognitive decline and neuropathologic deterioration seen in magnetic resonance imaging (MRI). Healthy lifestyle factors such as regular exercise may provide benefits to HIV+ individuals. Few studies
Aerobic Exercise Increases Cognition and Brain Volume in HIV+ People Read More »
HIV Lipodystrophy Update: Interview with Researcher Dr. Grace McComsey Dr. Grace McComsey has been involved in HIV research for 16 years, 12 of those as an NIH-funded principal investigator. Her work has focused on the investigations on lipodystrophy and metabolic complications in HIV. Her work was paramount in showing the link between nucleoside inhibitor-induced mitochondrial
HIV Lipodystrophy Update: Interview with Researcher Dr. Grace McComsey Read More »
The topic of mitochondrial damage is gaining more and more press as a potential side effect of anti-HIV medication. Simply put, the mitochondria are the “energy factories” of the cell —the tiny, rod-shaped structures, or “organelles,” within each cell responsible for producing roughly 90 percent of all the energy that cell needs in order to
How to Protect Your Mitochondria Read More »
FOR IMMEDIATE RELEASE For more information: Richard Jefferys Michael Palm Basic Science, Vaccines & Cure Project Director Treatment Action Group [email protected] Nelson Vergel Program for Wellness Restoration [email protected] PRESS RELEASE HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders. Dialogues with FDA, scientists and
The Die is Cast at the STARTDavid Alain Wohl, MD – The University of North Carolina at Chapel Hill —————————– “HIV medicine has transitioned from an oncological mode created to manage a progressive and complicated fatal disease to a model that more closely resembles a diabetes clinic, where lab metrics are used to plot a
Good News in Aging with HIV Read More »
Randomized controlled trial Lindboe JB, et al. Infect Dis (Lond). 2016 Nov-Dec. Authors Lindboe JB1, Langkilde A1, Eugen-Olsen J2, Hansen BR2,3, Haupt TH1, Petersen J1,4, Andersen O1,3. Author information 1a Optimed, Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre , Denmark ; 2b Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre
Low-dose growth hormone therapy reduces inflammation in HIV-infected patients Read More »
Ben Klein, a Senior Attorney from GLAD.org speaks about the new bill approved in the state of Massachusetts in Aug. 2016 that mandates several insurance carriers in that state to reimburse cost for HIV related lipodystrophy therapies and how activists can advocate for similar bills in other states. California is also trying to get a
New Bill Mandates Coverage of HIV Lipodystrophy Treatments Read More »
